Firm strengthens engineering resources to support private LLM deployments, AI automation, and enterprise data pipelinesSeattle-Tacoma, WA, ...

Lupin said on Tuesday it agreed to a $90-million settlement with Japan's Astellas Pharma in a patent dispute over the bladder disorder drug Mirabegron, a move that allows it to continue selling the pr ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...

The Python Software Foundation has rejected a $1.5 million government grant because of anti-DEI requirements imposed by the Trump administration, the nonprofit said in a blog post yesterday. The grant ...

remove-circle Internet Archive's in-browser video "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see your ...

Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...

Generic drugs are cheaper copies of brand drugs, offering significant savings to patients. Once a brand-name drug's patent expires, competitors can apply to make generic versions. Generic ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

Oct 3 (Reuters) - The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in ...